Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol ENPP1 contributors: mct - updated : 09-01-2013
HGNC name ectonucleotide pyrophosphatase/phosphodiesterase 1
HGNC id 3356
Corresponding disease
COLED Cole disease
HYP3 hypophosphatemic rickets 3
IIAC idiopathic generalized infantile arterial calcification
OPLL1 ossification of the posterior longitudinal ligament of spine
Location 6q23.2      Physical location : 132.129.155 - 132.216.293
Synonym name
  • membrane component,chr 6, surface marker 1
  • phosphodiesterase I/nucleotide pyrophosphatase 1
  • ectonucleotide pyrophosphatase/phosphodiesterase 1
  • plasma-cell membrane glycoprotein 1
  • Ly-41 antigen
  • Synonym symbol(s) M6S1, NPP1, NPPS, PC-1, PCA1, PDNP1
    EC.number 3.1.4.1, 3.6.1.9
    DNA
    TYPE functioning gene
    STRUCTURE 87.14 kb     25 Exon(s)
    10 Kb 5' upstream gene genomic sequence study
    MAPPING cloned Y linked N status confirmed
    RNA
    TRANSCRIPTS type messenger
    identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    25 - 7442 - 925 - 2005 15788404
    EXPRESSION
    Type widely
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Cardiovascularvessels    
    Digestivesalivary gland    
    Endocrineparathyroid   highly
    Hearing/Equilibriumearinnercochlea highly
    reproductiveepididymis    
    Urinarykidneytubule   
    tissue
    SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
    Blood / Hematopoietic    
    Connectiveadipose    Homo sapiens
    Lymphoid    
    cells
    SystemCellPubmedSpeciesStageRna symbol
     chondrocyte
    Lymphoid/Immuneactivated B lymphocyte
    Lymphoid/Immunemacrophage
    Skeletonosteoblast Homo sapiens
    cell lineage osteoblasts
    cell lines
    fluid/secretion
    at STAGE
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • a single TM region, active site containing a threonine residue
  • two somatomedin-B-like domains (SMB1 and 2) involved in ENPP1 dimerization, and are negative modulators of ENPP1 inhibitory activity on insulin signaling
  • nucleotide pyrophosphatase domain
  • a nuclease-like domain and a cytoplasmic tail
  • secondary structure nucleotides are accommodated in a pocket formed by an insertion loop in the catalytic domain, explaining the preference of Enpp1 for an ATP substrate
    conjugated GlycoP
    mono polymer homomer , dimer
    HOMOLOGY
    interspecies homolog to murine PC-1
    homolog to murine Ly-41 antigen
    Homologene
    FAMILY
  • nucleotide pyrophosphatase/phosphodiesterase family (ENPP)
  • CATEGORY enzyme
    SUBCELLULAR LOCALIZATION extracellular
        plasma membrane
    text membrane glycoprotein type 2
    basic FUNCTION
  • may play a role in the regulation of pyrophosphate production, the regulation of the availability of nucleotide sugars in the endoplasmic reticulum and golgi, and the regulation of purinergic signaling
  • producing inorganic pyrophosphate, a major inhibitor of calcification and mineralization (see OPLLS)
  • inhibits the insulin-receptor tyrosine kinase activity, resulting in reduced insulin sensitivity
  • inhibit insulin signaling, and inhibition of insulin signaling by ENPP1 is somewhat specific and is dependent upon the enzymatic activity of the phosphodiesterase/pyrophosphatase
  • affects insulin signaling and glucose metabolism in skeletal muscle- and liver-cells and both function and survival of insulin secreting beta-cells, thus representing a strong pathogenic factor predisposing to insulin resistance
  • negatively modulate insulin receptor, inducing cellular insulin resistance when overexpressed in various cell types
  • its expression is critical for osteoblastic differentiation and that this effect is not mediated by changes in extracellular concentration levels of phosphate or pyrophosphate or ENPP1 catalytic activity
  • plays multiple and distinct roles in the development of mineralized tissues and its influence on osteoblast differentiation and gene expression may include a mechanism that is independent of its catalytic activity
  • its expression is a necessary stimulator of osteoblast differentiation and that this effect is independent of extracellular inorganic phosphate and pyrophosphate generation and independent of ENPP1 enzymatic activity
  • essential for normal bone development and control of physiological bone mineralizationb
  • membrane-bound glycoprotein that regulates bone mineralization by hydrolyzing extracellular nucleotide triphosphates to produce pyrophosphate
  • responsible for the generation of inorganic pyrophosphate, a natural inhibitor of mineralization
  • role for ENPP1 in the regulation of epidermal differentiation and pigmentation
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
  • two identical disulfide bonded subunit of 120kDa
  • INTERACTION
    DNA
    RNA
    small molecule
    protein
  • interacting wirh HSPA4 (by affecting ENPP1 expression, may be a novel mediator of altered insulin signaling)
  • MSX2 is an additional mediator of ENPP1 gene expression
  • cell & other
  • plasma cell membrane
  • REGULATION
    induced by MSX2 and RUNX2, that function together to induce ENPP1 gene expression in osteoblastic cells
    ASSOCIATED DISORDERS
    corresponding disease(s) OPLL1 , IIAC , HYP3 , COLED
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    constitutional     --over  
    in non insulin-dependent diabetes
    constitutional     --over  
    associated with adipose tissue dysfunction, increased liver triglyceride deposition, and systemic insulin resistance in young normoglycemic men
    constitutional     --over  
    in the presence of a high-fat diet, ENPP1 overexpression in adipocytes induces fatty liver, hyperlipidemia, and dysglycemia, key manifestations of the metabolic syndrome (
    Susceptibility
  • to early myocardial infarction (controversial)
  • to severe obesity (controversial)
  • to metabolic syndrome
  • to obesity, insulin resistance, and early myocardial infarction
  • to altered glucose homeostasis
  • Variant & Polymorphism SNP , other
  • variant K121Q increases the risk of early myocardial infarction and of severe obesity
  • SNP K121Q, IVS20delT, A>G+1044TGA, increasing the risk of obesity with type 2 diabetes
  • the K121Q polymorphism associated with increased susceptibility to obesity and early impairment of glucose and insulin metabolism in children
  • homozygous carriers of the ENPP1 Q121 variant are characterized by an altered glucose homeostasis
  • K121Q variant is associated with obesity, insulin resistance, and early myocardial infarction
  • Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    diabete  
    inhibition of ENPP1 represents a potential strategy in treating diabetes
    ANIMAL & CELL MODELS
  • calvarial cells isolated from ENPP1-/- mice are defective in both osteoblastic gene expression and matrix mineralization
  • Enpp1(-/-) mice are characterized by severe disruption to the architecture and mineralization of long-bones, dysregulation of calcium/phosphate homeostasis and changes in Fgf23 expression
  • loss of Npp1 in the Enpp1 null mouse increased acellular cementum, with little effect on cellular cementum